Partnership & Sponsorship Overview
The Gap
Less than 0.3% of philanthropic giving benefits women's health research, and there is currently no validated, objective biomarker used to diagnose perimenopause in clinical practice. Women often go years before receiving an accurate diagnosis.
What We're Building
Biomarker Validation Study — A cross-sectional clinical study (300–400 women, ages 40–55) validating sdLDL-C as a standalone diagnostic marker for perimenopause, paired with the Menopause Rating Scale. Pursuing dual IRB pathways (hospital-based and independent).
Partnership Tiers
Tier Contribution What's Included
Supporting Partner $2,500–$10,000 Logo on website & materials, quarterly progress updates
Program Partner $10,000–$50,000 Above + named recognition in study materials, early access to findings, LinkedIn/social co-promotion
Founding Partner $50,000+ Above + seat on advisory input for pilot design, co- branded outreach opportunities, first-look at commercial pathway opportunities
In-kind contributions (lab services, data infrastructure, clinical staff time) are also welcome and can be structured as partial sponsorship credit.
Get In Touch
Liv Burkey, Founder, The Perimenopause Society